Literature DB >> 10339410

Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1.

W D Morgan1, B Birdsall, T A Frenkiel, M G Gradwell, P A Burghaus, S E Syed, C Uthaipibull, A A Holder, J Feeney.   

Abstract

The solution structure of the 96-residue C-terminal fragment of the merozoite surface protein 1 (MSP-1) from Plasmodium falciparum has been determined using nuclear magnetic resonance (NMR) spectroscopic measurements on uniformly13C/15N-labelled protein, efficiently expressed in the methylotrophic yeast Komagataella (Pichia) pastoris. The structure has two domains with epidermal growth factor (EGF)-like folds with a novel domain interface for the EGF domain pair interactions, formed from a cluster of hydrophobic residues. This gives the protein a U-shaped overall structure with the N-terminal proteolytic processing site close to the C-terminal glycosyl phosphatidyl inositol (GPI) membrane anchor site, which is consistent with the involvement of a membrane-bound proteinase in the processing of MSP-1 during erythrocyte invasion. This structure, which is the first protozoan EGF example to be determined, contrasts with the elongated structures seen for EGF-module pairs having shared Ca2+-ligation sites at their interface, as found, for example, in fibrillin-1. Recognition surfaces for antibodies that inhibit processing and invasion, and antibodies that block the binding of these inhibitory antibodies, have been mapped on the three-dimensional structure by considering specific MSP-1 mutants. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339410     DOI: 10.1006/jmbi.1999.2753

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  54 in total

1.  Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.

Authors:  David K Moss; Edmond J Remarque; Bart W Faber; David R Cavanagh; David E Arnot; Alan W Thomas; Anthony A Holder
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

Review 2.  Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.

Authors:  Jacqueline Sharon; Michael J Rynkiewicz; Zhaohua Lu; Chiou-Ying Yang
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

3.  Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts.

Authors:  George Hui; Dan Choe; Caryn Hashimoto
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

4.  Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.

Authors:  Suman Mazumdar; Paushali Mukherjee; Syed Shams Yazdani; S K Jain; Asif Mohmmed; Virander Singh Chauhan
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

5.  Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.

Authors:  Changling Li; Rui Wang; Yuan Wu; Dongmei Zhang; Zhicheng He; Weiqing Pan
Journal:  Malar J       Date:  2010-04-12       Impact factor: 2.979

6.  Lineage-specific positive selection at the merozoite surface protein 1 (msp1) locus of Plasmodium vivax and related simian malaria parasites.

Authors:  Hiromi Sawai; Hiroto Otani; Nobuko Arisue; Nirianne Palacpac; Leonardo de Oliveira Martins; Sisira Pathirana; Shiroma Handunnetti; Satoru Kawai; Hirohisa Kishino; Toshihiro Horii; Kazuyuki Tanabe
Journal:  BMC Evol Biol       Date:  2010-02-19       Impact factor: 3.260

7.  Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria.

Authors:  Heng Peng; Yunfei Hu; Aiguo Zhou; Changwen Jin; Weiqing Pan
Journal:  Malar J       Date:  2010-03-18       Impact factor: 2.979

8.  Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.

Authors:  Sedigheh Zakeri; Akram A Mehrizi; Samaneh Zoghi; Navid D Djadid
Journal:  Malar J       Date:  2010-09-16       Impact factor: 2.979

9.  Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.

Authors:  Shigeto Yoshida; Hiroshi Nagumo; Takashi Yokomine; Hitomi Araki; Ayaka Suzuki; Hiroyuki Matsuoka
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum.

Authors:  Elke S Bergmann-Leitner; Elizabeth H Duncan; Evelina Angov
Journal:  Malar J       Date:  2009-08-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.